A new AI system called TrialGPT 2.0 has been developed to assist in matching cancer patients with clinical trials, aiming to improve enrollment rates and reduce screening time. This system was evaluated across multiple oncology settings, including government and academic institutions, and demonstrated a significant improvement in identifying suitable trials. TrialGPT 2.0 successfully retrieved clinician-recommended trials for approximately 91% of cases in retrospective evaluations and expanded patient access to trial opportunities by over 90% in a prospective study. To facilitate further research, the developers also introduced NIH-TrialBench, a dataset of synthetic patient vignettes for evaluating AI matching systems. AI
IMPACT Enhances efficiency in clinical trial matching and potentially accelerates cancer drug development by improving patient access to trials.
RANK_REASON The cluster describes a research paper detailing a new AI system and dataset for clinical trial matching. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →